{
  "main_header": {
    "sid": 10039862,
    "name": "Sudeep Pharma",
    "stock_name": "Sudeep Pharma",
    "full_name": "Sudeep Pharma Ltd",
    "name_url": "stocks-analysis/sudeep-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "608.70",
    "chg": 12.75,
    "chgp": "2.14%",
    "dir": 1,
    "prev_price": "595.95",
    "mcapval": "6,858.00 Cr",
    "mcap": "",
    "scripcode": 544619,
    "symbol": "SUDEEPPHRM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE0QPI01025",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "68.05 k",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/sudeep-pharma-10039862-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 0,
    "sid": "10039862",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/sudeep-pharma-10039862"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Approval Of Unaudited Financial Results As On 31St December 2025 Along With Other Business Items",
      "datetime": "02-Feb-2026",
      "details": "Sudeep Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2026 inter alia to consider and approve Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and Nine Months ended on 31st December 2025 along with other business items.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "02-Feb-2026",
      "details": "This is to inform that the Earnings Call of the Company with Analysts/Investors to discuss the operational & financial performance for the quarter and nine ended on December 31 2025 is scheduled as below: Day & Date: Monday 09th February 2026 Time: 11:30 a.m. IST Registration Link and Access numbers: As per Annexure",
      "source": "BSE"
    },
    {
      "caption": "Announcement Under Regulation 30 (LODR) - Intimation Of Approval For Purchase Of Rights In Leasehold Land In GIDC By Sudeep Advanced Materials Private Limited A Wholly Owned Subsidiary (WOS) Of The Company.",
      "datetime": "22-Jan-2026",
      "details": "We hereby inform you that the Companys Wholly Owned Subsidiary i.e. Sudeep Advanced Materials Private Limited has purchased the rights in leasehold land in Dahej Gujarat (GIDC) from DCM Shriram Fine Chemicals Limited.",
      "source": "BSE"
    }
  ],
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

No Recent News for the Company

View All News